Anti-craving medications for alcohol to treat moderate to severe alcohol use disorder

被引:0
|
作者
Mong, Jon [1 ]
Ahamad, Keith [2 ,4 ]
Bach, Paxton [3 ,4 ]
机构
[1] Univ Ottawa, Div Med Interne Gen, Ottawa, ON, Canada
[2] Univ British Columbia, Dept Med Familiale, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[4] Hop St Paul, Ctr Traitement Toxicomanie Colombie Britannique, Vancouver, BC, Canada
关键词
D O I
10.1503/cmaj.200895-f
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1196 / E1197
页数:2
相关论文
共 50 条
  • [1] Prescribing Pattern of Anti-Craving Drugs Among Alcohol Use Disorder Patients
    Dsouza, Prizvan Lawrence
    Krishna, Hattikuduru Vamsi
    Viswam, Subeesh Kulangara
    Singh, Hemendra
    [J]. ALCOHOLISM TREATMENT QUARTERLY, 2023, 41 (04) : 462 - 473
  • [2] Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence for SAEM GRACE
    Punia, Kiran
    Scott, William
    Manuja, Kriti
    Sabbineni, Monica
    Campbell, Kaitryn
    Balodis, Iris M.
    Mackillop, James
    [J]. ACADEMIC EMERGENCY MEDICINE, 2024, 31 (05) : 504 - 514
  • [3] Choosing Appropriate Anti-craving Pharmacotherapy for Alcohol and Opioid Use Disorder : A Psychopharmacological Approach
    Saha, Indranil
    Barua, Supartha
    Mondal, Arijit
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S165 - S165
  • [4] Evidence for alcohol anti-craving properties of memantine
    Holter, SM
    Danysz, W
    Spanagel, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (03) : R1 - R2
  • [5] Acamprosate-an Anti-Craving Drug for Alcohol Use Disorder (AUD) Pharmacotherapy: Plasma Metabolomics Signatures are Associated With Alcohol Craving Intensity and Acamprosate Treatment Response
    Ho, Ming-Fen
    Zhang, Cheng
    Zhang, Lingxin
    Moon, Irene
    Geske, Jennifer
    Choi, Doo-Sup
    Biernacka, Joanna
    Oesterle, Tyler
    Frye, Mark
    Seppala, Marvin
    Li, Hu
    Karpyak, Victor
    Weinshilboum, Richard
    [J]. BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S139 - S140
  • [6] Role of Acamprosate and Baclofen as Anti-craving Agents in Alcohol Use Disorder: A 12-Week Prospective Study
    Sharma, Akhilesh K.
    Rikhari, Praveen
    Shukla, Alok K.
    Rikhari, Pragya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [7] ACAMPROSATE-AN ANTI-CRAVING DRUG FOR ALCOHOL USE DISORDER (AUD) PHARMACOTHERAPY: PLASMA METABOLOMICS SIGNATURES ARE ASSOCIATED WITH ALCOHOL CRAVING INTENSITY AND ACAMPROSATE TREATMENT RESPONSE.
    Ho, M.
    Zhang, C.
    Zhang, L.
    Moon, I.
    Geske, J.
    Choi, D.
    Biernacka, J.
    Oesterle, T.
    Frye, M.
    Seppala, M.
    Li, H.
    Karpyak, V.
    Weinshilboum, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S18 - S18
  • [8] Medications to Treat Alcohol Use Disorder: Targeting the Dark Side
    Mason, Barbara J.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (05): : 375 - 377
  • [9] Medications for Alcohol Use Disorder and Predicting Severe Withdrawal
    Saitz, Richard
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (08): : 766 - 768
  • [10] Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder
    Ehrie, Jarrod
    Hartwell, Emily E.
    Morris, Paige E.
    Mark, Tami L.
    Kranzler, Henry R.
    [J]. FRONTIERS IN PSYCHIATRY, 2020, 11